はじめての方へショーケース価格
  1. 米国企業
  2. PTC THERAPEUTICS, INC.

PTC THERAPEUTICS, INC.PTCT

時価総額
$25.4億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net loss-51,573,575-94-170-142-79-128-252-438-524-559-627
Depreciation and amortization----1826324364129237
Non-cash operating lease expense-------671010
Non-cash finance lease amortization expense------441---
Non-cash royalty revenue related to sale of future royalties-------2234993
Non-cash royalty revenue related to sale of future royalties-------2234993
Noncash Interest Expense, Liability Related to Sale of Future Royalties-------327873105
Noncash Interest Expense, Liability Related to Sale of Future Royalties-------327873105
Intangible asset impairment---------33218
Intangible asset impairment---------33218
Change in valuation of contingent consideration-----194823-0-26-128
Change in valuation of contingent consideration-----194823-0-26-128
Unrealized loss on ClearPoint Equity Investments---------6-4-2
Settlement of deferred and contingent consideration-------11---
Unrealized loss on ClearPoint convertible debt security-------19-8-6-3
Shares issued Asset Acquisition-------43---
Unrealized (gain) loss on marketable securities - equity investments-------142-83
Unrealized loss on ClearPoint Equity Investments---------6-4-2
Realized loss for the sale of Clearpoint Equity Investment-----------1
Unrealized loss on ClearPoint convertible debt security-------19-8-6-3
Realized gain on redemption of marketable securities- equity investments----------4
Unrealized (gain) loss on marketable securities - equity investments-------142-83
Issuance of Stock for Milestone Payment----------30
Disposal of asset--0--0-0-0-0--0-1
Deferred income taxes----00-960-34-47
Amortization of (discounts) premiums on investments, net--2-2-2-102-0-5-22
Amortization of (discounts) premiums on investments, net--2-2-2-102-0-5-22
Deferred income taxes----00-960-34-47
Amortization of debt issuance costs--000111222
Share-based compensation expense819343531334270104110102
Loss on extinguishment of debt-----------56
Paid-in-Kind Interest6-26781223---
Share-based compensation expense819343531334270104110102
Unrealized foreign currency transaction (gains) losses, net----1001257-47-1314
Non cash foreign currency remeasurement loss on intercompany loan----------17-
Inventory, net----663-2-278
Prepaid expenses and other current assets760,50122-122913155245
Trade and royalty receivables, net-56,09137151230-121045482
Deposits and other assets-48,0420-001118103-5
Accounts payable and accrued expenses51717424442771462848
Other liabilities------14-4-7-5-2
Deferred revenue-----7-1-8-41-1
Payments on contingent consideration----------10-
Net cash used in operating activities----104-10-28-99-194-251-357-158
Purchases of fixed assets845,732532371418283228
Purchases of marketable securities - available for sale-------1033353174
Purchases of marketable securities - equity investments1562482248581694941,4402102338
Purchases of marketable securities - equity investments1562482248581694941,4402102338
Proceeds from Sale of Debt Securities, Available-for-sale--------84340522
Proceeds from Sale of Debt Securities, Available-for-sale--------84340522
Proceeds from Sale and Maturity of Marketable Securities29107206192175901569444113132
Proceeds from Sale and Maturity of Marketable Securities29107206192175901569444113132
Sale and redemption of ClearPoint Equity Investments----------3
Acquisition of product rights and licenses----77832385712092
Purchase of equity investment in ClearPoint------4-0--
Net cash (used in) provided by investing activities---10413-43-387-562219290-177
Proceeds from exercise of options-1912111870171524
Termination and exit fees related to payoff of secured term loan-------1--82
Repayment of senior secured term loan------1228--300
Net proceeds from public offerings-236---11832428---
Debt extinguishment costs related to senior secured term loan-------1--82
Debt issuance costs related to secured term loan--5------110
Proceeds From Sale of Future Royalties-------650--1,000
Proceeds from Issuance of Secured Debt----40----300-
Debt issuance costs related to secured term loan--5------110
Repayment of Convertible Notes---------150-
Proceeds from Issuance of Secured Debt----40----300-
Payments on deferred and contingent consideration obligation-------38-40-
Repayment of Convertible Notes---------150-
Proceeds from Stock Plans----2345666
Payments on deferred and contingent consideration obligation-------38-40-
Payment of finance lease principal-------18211
Proceeds from Stock Plans----2345666
Proceeds from stock purchase agreement---------50-
Payment of finance lease principal-------18211
Proceeds From Sale of Future Royalties-------650--1,000
Proceeds from stock purchase agreement---------50-
Net cash provided by financing activities---14413261366921168646
Effect of exchange rate changes on cash----------33
Net increase (decrease) in cash and cash equivalents------126-79-1999314
Cash paid for interest------810101836
Income Taxes Paid, Net2,077-01122268514
Unrealized gain (loss) on marketable securities, net of tax-------1-301
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability------1777136-
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability-------41---
Acquisition of product rights and licenses-----61114223355
Acquisition of product rights and licenses-----61114223355
Stock Issued During Period, Value, Exchange Rights-------151---
Debt issuance costs related to senior secured term loan---------0-
Debt issuance costs related to senior secured term loan---------0-
Capital Expenditures Incurred but Not yet Paid-------1-0-
Capital Expenditures Incurred but Not yet Paid-------1-0-